Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation: Effect of p53

Yeun Jin Ju, Jeong Eun Park, Kyoung Mi Juhn, Jaemin Jeong, Miyong Yun, Myung Jin Park, Gil Hong Park, Kang-Yell Choi, Myung Haeng Cho, Kwok Kin Wong, Won Bong Park, Kee Ho Lee

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Loss of p53 tumor suppressor facilitates acquisition of telomerase activity. In fact, both p53 inactivation and telomerase activation are frequently found in human cancers. p53 inactivation, however, eliminates or attenuates the biological responses to telomerase inhibition and the eventual telomere erosion. We show that telomere erosion can increase the susceptibility to radiation, irrespective of p53 status. Both telomerase inhibition and critically shortened telomere with significant change of chromosomal end-to-end fusion were essential for the enhancement of radiosensitivity. The enhancement was correlated with greater formation of multinucleated cells. p53 inactivation did not eliminate the observed generation of chromosomal fusion and multinucleation, and the resulting increased susceptibility to radiation, as opposed to the previously proved role of p53 in mediating cellular responses to telomere dysfunction. The present findings suggest the importance of chromosomal end fusion in modulating radiosensitivity rather than p53 DNA damage signaling. Thus, the suggested anticancer radiotherapeutic strategy combined with telomerase inhibition could clinically be applicable to cancers, irrespective of p53 status.

Original languageEnglish
Pages (from-to)753-763
Number of pages11
JournalInternational journal of oncology
Volume29
Issue number4
Publication statusPublished - 2006 Oct 1

Fingerprint

Telomerase
Telomere
Radiation
Radiation Tolerance
Telomere Shortening
Neoplasms
DNA Damage

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Ju, Y. J., Park, J. E., Juhn, K. M., Jeong, J., Yun, M., Park, M. J., ... Lee, K. H. (2006). Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation: Effect of p53. International journal of oncology, 29(4), 753-763.
Ju, Yeun Jin ; Park, Jeong Eun ; Juhn, Kyoung Mi ; Jeong, Jaemin ; Yun, Miyong ; Park, Myung Jin ; Park, Gil Hong ; Choi, Kang-Yell ; Cho, Myung Haeng ; Wong, Kwok Kin ; Park, Won Bong ; Lee, Kee Ho. / Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation : Effect of p53. In: International journal of oncology. 2006 ; Vol. 29, No. 4. pp. 753-763.
@article{5190008658874f16b1080ff0a8ba0d5b,
title = "Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation: Effect of p53",
abstract = "Loss of p53 tumor suppressor facilitates acquisition of telomerase activity. In fact, both p53 inactivation and telomerase activation are frequently found in human cancers. p53 inactivation, however, eliminates or attenuates the biological responses to telomerase inhibition and the eventual telomere erosion. We show that telomere erosion can increase the susceptibility to radiation, irrespective of p53 status. Both telomerase inhibition and critically shortened telomere with significant change of chromosomal end-to-end fusion were essential for the enhancement of radiosensitivity. The enhancement was correlated with greater formation of multinucleated cells. p53 inactivation did not eliminate the observed generation of chromosomal fusion and multinucleation, and the resulting increased susceptibility to radiation, as opposed to the previously proved role of p53 in mediating cellular responses to telomere dysfunction. The present findings suggest the importance of chromosomal end fusion in modulating radiosensitivity rather than p53 DNA damage signaling. Thus, the suggested anticancer radiotherapeutic strategy combined with telomerase inhibition could clinically be applicable to cancers, irrespective of p53 status.",
author = "Ju, {Yeun Jin} and Park, {Jeong Eun} and Juhn, {Kyoung Mi} and Jaemin Jeong and Miyong Yun and Park, {Myung Jin} and Park, {Gil Hong} and Kang-Yell Choi and Cho, {Myung Haeng} and Wong, {Kwok Kin} and Park, {Won Bong} and Lee, {Kee Ho}",
year = "2006",
month = "10",
day = "1",
language = "English",
volume = "29",
pages = "753--763",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "4",

}

Ju, YJ, Park, JE, Juhn, KM, Jeong, J, Yun, M, Park, MJ, Park, GH, Choi, K-Y, Cho, MH, Wong, KK, Park, WB & Lee, KH 2006, 'Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation: Effect of p53', International journal of oncology, vol. 29, no. 4, pp. 753-763.

Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation : Effect of p53. / Ju, Yeun Jin; Park, Jeong Eun; Juhn, Kyoung Mi; Jeong, Jaemin; Yun, Miyong; Park, Myung Jin; Park, Gil Hong; Choi, Kang-Yell; Cho, Myung Haeng; Wong, Kwok Kin; Park, Won Bong; Lee, Kee Ho.

In: International journal of oncology, Vol. 29, No. 4, 01.10.2006, p. 753-763.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation

T2 - Effect of p53

AU - Ju, Yeun Jin

AU - Park, Jeong Eun

AU - Juhn, Kyoung Mi

AU - Jeong, Jaemin

AU - Yun, Miyong

AU - Park, Myung Jin

AU - Park, Gil Hong

AU - Choi, Kang-Yell

AU - Cho, Myung Haeng

AU - Wong, Kwok Kin

AU - Park, Won Bong

AU - Lee, Kee Ho

PY - 2006/10/1

Y1 - 2006/10/1

N2 - Loss of p53 tumor suppressor facilitates acquisition of telomerase activity. In fact, both p53 inactivation and telomerase activation are frequently found in human cancers. p53 inactivation, however, eliminates or attenuates the biological responses to telomerase inhibition and the eventual telomere erosion. We show that telomere erosion can increase the susceptibility to radiation, irrespective of p53 status. Both telomerase inhibition and critically shortened telomere with significant change of chromosomal end-to-end fusion were essential for the enhancement of radiosensitivity. The enhancement was correlated with greater formation of multinucleated cells. p53 inactivation did not eliminate the observed generation of chromosomal fusion and multinucleation, and the resulting increased susceptibility to radiation, as opposed to the previously proved role of p53 in mediating cellular responses to telomere dysfunction. The present findings suggest the importance of chromosomal end fusion in modulating radiosensitivity rather than p53 DNA damage signaling. Thus, the suggested anticancer radiotherapeutic strategy combined with telomerase inhibition could clinically be applicable to cancers, irrespective of p53 status.

AB - Loss of p53 tumor suppressor facilitates acquisition of telomerase activity. In fact, both p53 inactivation and telomerase activation are frequently found in human cancers. p53 inactivation, however, eliminates or attenuates the biological responses to telomerase inhibition and the eventual telomere erosion. We show that telomere erosion can increase the susceptibility to radiation, irrespective of p53 status. Both telomerase inhibition and critically shortened telomere with significant change of chromosomal end-to-end fusion were essential for the enhancement of radiosensitivity. The enhancement was correlated with greater formation of multinucleated cells. p53 inactivation did not eliminate the observed generation of chromosomal fusion and multinucleation, and the resulting increased susceptibility to radiation, as opposed to the previously proved role of p53 in mediating cellular responses to telomere dysfunction. The present findings suggest the importance of chromosomal end fusion in modulating radiosensitivity rather than p53 DNA damage signaling. Thus, the suggested anticancer radiotherapeutic strategy combined with telomerase inhibition could clinically be applicable to cancers, irrespective of p53 status.

UR - http://www.scopus.com/inward/record.url?scp=39049184615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39049184615&partnerID=8YFLogxK

M3 - Article

C2 - 16964373

AN - SCOPUS:39049184615

VL - 29

SP - 753

EP - 763

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 4

ER -